Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Tumor-Agnostic 1Genitourinary 1

Conditions

Small Cell Lung Carcinoma 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Magnetic Resonance Spectroscopy 262Specimen Handling 253pembrolizumab 230Cyclophosphamide 216Radiotherapy 204Nivolumab 168Cisplatin 161Carboplatin 145Biopsy 144Radiosurgery 128fludarabine 123Blood Specimen Collection 116Gemcitabine 111Paclitaxel 107Surveys and Questionnaires 106Standard of Care 102venetoclax 94Dexamethasone 93Bevacizumab 92Radiation 87Rituximab 81Capecitabine 80Cytarabine 79Oxaliplatin 77Drug Therapy 75Doxorubicin 75Ipilimumab 73durvalumab 70fludarabine phosphate 69atezolizumab 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × monalizumab × 90 days × Clear all
NCT07146230 2026-05-06

SPRINT 2

Montefiore Medical Center

Phase 2 Not yet recruiting
52 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05903092 2026-04-29

MOZART

Hoosier Cancer Research Network

Phase 2 Recruiting
84 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06503614 2026-04-08

ENHANCE

Hoosier Cancer Research Network

Phase 2 Recruiting
60 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06152523 2026-04-06

MONAMI

Assistance Publique - Hôpitaux de Paris

Phase 2 Withdrawn
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡